Building off of the success of last year’s Allicense, Locust Walk will co-host Allicense 2015 in San Francisco from May 5 – 6. Please contact Chris Ehrlich for additional information, chris@locustwalkpartners.com.”
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Strategic Science and Technologies LLC (SST) today announced the signing of an option agreement with one of the world’s largest over-the-counter (OTC) healthcare companies. The partner has received an exclusive option to...
(Menlo Park, CA, United States and Grande Bay, Mauritius) October 20, 2014 – TesoRx Pharma, LLC, a specialty pharmaceutical company, announced today that it has licensed select international rights to TSX-002, the first unmodified oral-Testosterone replacement...
The Locust Walk Partners team is proud to share with you today’s news that our client, Armetheon, Inc., completed its Series A financing, raising an over-subscribed Series A round of $7M. The round was co-led by AshHill Biomedical Investments and Hercules Bioventures...
Senesco Completes Acquisition of Fabrus Press Release May 19, 2014 8:30 am BRIDGEWATER, N.J.–(BUSINESS WIRE)– Senesco Technologies, Inc. (“Senesco” or the “Company”) (SNTI), completed its acquisition of Fabrus, Inc. (“Fabrus”), a biotechnology company...
